“Global translational regenerative medicine market set to grow to $95bn by 2024,” says Visiongain

Visiongain has published a new Pharma Report Top 25 Translational Regenerative Medicine Manufacturers 2019: Medtronic, Acelity, Integra Lifesciences, NuVasive, Orthofix International, Anika Therapeutics, Organogenesis, UniQure, TiGenix, Vericel Corporation and other Companies.

In 2018, the global translational regenerative medicine was estimated to be worth $28bn. The global translational regenerative medicine market is highly competitive and fragmented with the presence of several vendors. Competition is likely to increase with advances in R&D and technological innovations. The market is characterised by the presence of well-diversified international and local vendors that provide cost-effective products with limited features and functionalities.

Download free report sample pages: https://www.visiongain.com/report/top-25-translational-regenerative-medicine-manufacturers-2019/

This report profiled the selected companies: Medtronic, Acelity, Integra Lifesciences, NuVasive, Orthofix International, Anika Therapeutics, Organogenesis, UniQure, TiGenix, Vericel Corporation and other selected companies.

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on 020 7549 9987

The lead analyst commented that “Advancements in biological sciences have shown a positive influence on the regenerative medicine market. There are new technological advancements in terms of drug manufacturing, development, and delivery. Many cell therapy products based on mesenchymal stem cells are available in the market because of their self-renewal ability and their presence in almost all tissues. The discovery of novel scaffolds and various growth and control factors have shown promising results in stimulating tissue formation. This has led to a shift in the focus to regenerative therapies over conventional methods of treatment.”

Related reports:

Global Cancer Immunotherapy Market Forecast 2019-2029:

https://www.visiongain.com/report/global-cancer-immunotherapy-market-forecast-2019-2029/

Global Biosimilars and Follow-On Biologics Market 2019-2029:

https://www.visiongain.com/report/global-biosimilars-and-follow-on-biologics-market-2019-2029/

Translational Regenerative Medicine Market Forecast 2019-2029:

https://www.visiongain.com/report/translational-regenerative-medicine-market-forecast-2019-2029/

For more pharma reports, visit our website: https://www.visiongain.com/industries/pharma/

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on 020 7549 9987

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, we produce a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Visiongain Limited
Airport House
Purley Way
Surrey
London
CR0 0XZ
United Kingdom

This release was published on openPR.